The usefulness of diphenylhydantoin in treatment of non-epileptic emotional disorders.
D000367:Age Factors; D002462:Cell Membrane / Q000502:physiology; D003863:Depression / Q000188:drug therapy; D004569:Electroencephalography; D004644:Emotions / Q000187:drug effects*; D004827:Epilepsy / Q000188:drug therapy; D005239:Fear; D005260:Female; D006261:Headache / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009474:Neurons / Q000502:physiology; D010672:Phenytoin / Q000627:therapeutic use*; D010698:Phobic Disorders / Q000188:drug therapy; D011581:Psychological Tests; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011613:Psychotherapy; D012737:Sex Factors; D012893:Sleep Wake Disorders / Q000188:drug therapy; D012964:Sodium / Q000502:physiology
D010672:Phenytoin; D012964:Sodium